Familial Mediterranean fever and seronegative arthritis

Current Rheumatology Reports

Volumn 13, Issue 5, 2011, Pages 388-394

  Akkoc, Nurullah ^a   Gul, Ahmet ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Familial mediterranean fever; MEFV; Pyrin; Seronegative arthritis; Spondyloarthritis

Indexed keywords

INTERLEUKIN 1BETA; PYRIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; CASE STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FAMILIAL MEDITERRANEAN FEVER; FAMILY HISTORY; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GEOGRAPHY; HETEROZYGOTE; HUMAN; MEDICAL HISTORY; MEFV GENE; POLYSEROSITIS; PREVALENCE; RECURRENT DISEASE; RISK FACTOR; SACROILIITIS; SPONDYLOARTHROPATHY;

AUTOANTIBODIES; BIOLOGICAL MARKERS; COMORBIDITY; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; JOINTS; MALE; PREVALENCE; RISK FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 80755132082     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0191-9     Document Type: Article

References (60)

1. Onen F. Familial Mediterranean fever. Rheumatol Int. 2006;26:489-96.
2. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25-31.
3. International FMF. Consortium: Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997;90:797-807.
4. •• Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009, 27:621-668. The authors in this review proposed an updated classification for hereditary and acquired forms of autoinflammatory disorders based on molecular pathophysiology. FMF and AS are both included but in different categories.
5. Infevers: an online database for autoinflammatory mutations. Available at http://fmf.igh.cnrs.fr/ISSAID/infevers. Accessed March 2, 2011.
6. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473-83. (Pubitemid 32750487)
7. • Marek-Yagel D, Bar-Joseph I, Pras E, Berkun Y. Is E148Q a benign polymorphism or a disease-causing mutation? The Journal of Rheumatology 2009, 36:2372. The authors extracted the data on E148Q from four published studies and found no difference between the Israeli controls and FMF patients.
8. Heller H, Gafni J, Michaeli D, et al. The arthritis of familial Mediterranean fever (FMF). Arthritis Rheum. 1966;9:1-17.
9. Garcia-Gonzalez A, Weisman MH. The arthritis of familial Mediterranean fever. Semin Arthritis Rheum. 1992;22:139-50. (Pubitemid 23007018)
10. Majeed HA, Rawashdeh M. The clinical patterns of arthritis in children with familial Mediterranean fever. QJM. 1997;90:37-43. (Pubitemid 27075850)
11. Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R. The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum. 2001;44:1416-9. (Pubitemid 32537542)
12. Sneh E, Pras M, Michaeli D, et al. Protracted arthritis in familial Mediterranean fever. Rheumatol Rehabil. 1977;16:102-6. (Pubitemid 8107715)
13. Kaushansky K, Finerman GA, Schwabe AD. Chronic destructive arthritis in familial Mediterranean fever: the predominance of hip involvement and its management. Clin Orthop Relat Res. 1981:156-161. (Pubitemid 11145881)
14. Salai M, Langevitz P, Blankstein A, et al. Total hip replacement in familial Mediterranean fever. Bull Hosp Jt Dis. 1993;53:25-8. (Pubitemid 23227968)
15. Brik R, Shinawi M, Kepten I, et al. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics. 1999;103:e70.
16. Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84:1-11. (Pubitemid 40130180)
17. Cefle A, Kamali S, Sayarlioglu M, et al. A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol Int. 2005;25:442-6. (Pubitemid 41186913)
18. Dilsen N. [Familial Mediterranean fever (periodic disease) associated with ankylopoietic spondylitis. (Apropos of a case)]. Turk Tip Cemiy Mecm. 1963;29:160-7.
19. Dilsen NA. Ankylosing spondylitis in familial Mediterranean fever (periodic disease). Excerpta Medica Intern Congr ser 1973;299:107.
20. Yazici H, Turunc M, Ozdogan H, et al. Observer variation in grading sacroiliac radiographs might be a cause of 'sacroiliitis' reported in certain disease states. Ann Rheum Dis. 1987;46:139-45. (Pubitemid 17015719)
21. Brodey PA, Wolff SM. Radiographic changes in the sacroiliac joints in familial Mediterranean fever. Radiology. 1975;114:331-3.
22. Langevitz P, Livneh A, Zemer D, et al. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum. 1997;27:67-72. (Pubitemid 27461152)
23. • Baraliakos X, Listing J, von der Recke A, Braun J. The natural course of radiographic progression in ankylosing spondylitis-evidence for major individual variations in a large proportion of patients. Rheumatol. 2009, 36:997-1002. This study indicates that radiographic progression in AS is rather variable, and the authors propose to differentiate patients as fast, moderate, and slow radiographic progressors based on development of new syndesmophytes over time.
24. Boonen A, vander Cruyssen B, de Vlam K, et al. Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J Rheumatol. 2009;36:1249-55.
25. Nash P, Mease PJ, Braun J, van der Heijde D. Seronegative spondyloarthropathies: to lump or split? Ann Rheum Dis. 2005;64 SUPPL. 2:ii9-13.
26. Younes M, Kahn MF, Meyer O. Hip involvement in patients with familial Mediterranean fever. A review of ten cases. Joint Bone Spine. 2002;69:560-5. (Pubitemid 36050357)
27. •• Kasifoglu T, Calisir C, Cansu DU, Korkmaz C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 2009, 28:41-46. This study investigated the presence of sacroiliitis among FMF patients using MRI of the sacroiliac joints in addition to conventional radiography, and found a higher-than-expected prevalence of sacroiliitis. Almost all patients with FMF and sacroiliitis carried at least one allele of the M694V variant.
28. Akar S, Soysal O, Yuksel F, et al. High prevalence of axial spondyloarthritis in patients with familial Mediteranean fever, and a greater allelic frequency of M694V in familial Mediteranean fever patients with radiograpic sacroiliitis. Arthritis Rheum. 2010, 62:S278.
29. Knockaert DC, Malysse IG, Peetermans WE. Ankylosing spondylitis. An unusual manifestation of familial Mediterranean fever. Report of a case complicated by amyloidosis and polyneuropathy. Clin Rheumatol. 1989;8:408-12. (Pubitemid 20111414)
30. Sari I, Simsek I, Guvenc I, et al. Osteopoikilosis coexistent with ankylosing spondylitis and familial Mediterranean fever. Rheumatol Int. 2009;29:321-3.
31. Duman I, Balaban B, Tugcu I, Dincer K. Familial mediterranean fever unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role? Rheumatol Int. 2007;27:689-90. (Pubitemid 46625351)
32. Kaushik P, el-Sobkie NI, Shehab D, Malaviya AN. Familial Mediterranean fever with HLA B-27 positive ankylosing spondylitis in a young Armenian man. Clin Exp Rheumatol. 1999;17:387-8. (Pubitemid 29265693)
33. Keles I, Aydin G, Tosun A, et al. Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: a case report and review of the literature. Rheumatol Int. 2006;26:846-51. (Pubitemid 43881812)
34. Akar S, Birlik M, Sari I, et al. M694V mutation may have a role in susceptibility to ankylosing spondylitis. Rheumatol Int. 2009;29:1259-60.
35. •• Cosan F, Ustek D, Oku B, et al. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum. 2010, 62:3232-3236. This study reported a significantly higher frequency of M694Vamong AS patients with no personal or family history of FMF as compared with healthy controls.
36. •• Akkoc N, Sari I, Akar S, et al. Increased prevalence of M694V in patients with ankylosing spondylitis: additional evidence for a link with familial Mediterranean fever. Arthritis Rheum. 2010, 62:3059-3063. This study reported a significantly higher frequency of M694Vamong AS patients than in healthy controls and patients with rheumatoid arthritis.
37. Durmus D, Alayli G, Cengiz K, et al. Clinical significance of MEFV mutations in ankylosing spondylitis. Joint Bone Spine. 2009;76:260-4.
38. Akkoc N, Gul A. Comment on the article by Durmus et al. "Clinical significance of MEFV mutations in ankylosing spondylitis'. Joint Bone Spine. 2010;77:281.
39. Cinar M, Dinc A, Simsek I, et al. The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int. 2008;29:37-42.
40. Maras Y, Calguneri M, Akdogan A, et al. MEFV mutations frequency and effect on disease severity in ankyloing spondylitis EULAR Meeting Abstracts. 2007, 66:400.
41. •• Reveille JD. The genetic basis of spondyloarthritis. Ann Rheum Dis. 2011, 70 SUPPL. 1:i44-50. This is a very comprehensive review on the genetics of AS.
42. Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329-37. (Pubitemid 350041542)
43. •• Reveille JD, Sims AM, Danoy P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet. 2010, 42:123-127. This recent genome-wide association study confirmed the strong association of the HLA-B region and also revealed several non-HLA susceptibility genes for AS.
44. Sims AM, Timms AE, Bruges-Armas J, et al. Prospective metaanalysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis. 2008;67:1305-9.
45. Carter KW, Pluzhnikov A, Timms AE, et al. Combined analysis of three whole genome linkage scans for ankylosing spondylitis. Rheumatology (Oxford). 2007;46:763-71. (Pubitemid 47061705)
46. •• Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol. 2010, 10:89-102. This paper provided a very comprehensive review of the IL-1 family in health and disease.
47. Chae JJ, Wood G, Richard K, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood. 2008;112:1794-803.
48. Yu JW, Wu J, Zhang Z, et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ. 2006;13:236-49. (Pubitemid 43102207)
49. Papin S, Cuenin S, Agostini L, et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ. 2007;14:1457-66. (Pubitemid 47096500)
50. Waite AL, Schaner P, Hu C, et al. Pyrin and ASC co-localize to cellular sites that are rich in polymerizing actin. Exp Biol Med (Maywood). 2009;234:40-52.
51. Shiohara M, Taniguchi S, Masumoto J, et al. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun. 2002;293:1314-8. (Pubitemid 34681019)
52. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417-26. (Pubitemid 35007355)
53. Dowds TA, Masumoto J, Chen FF, et al. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun. 2003;302:575-80. (Pubitemid 36279569)
54. Stehlik C, Lee SH, Dorfleutner A, et al. Apoptosis-associated speck-like protein containing a caspase recruitment domain is aregulator of procaspase-1 activation. J Immunol. 2003;171:6154-63. (Pubitemid 37467238)
55. Lachmann HJ, Sengul B, Yavuzsen TU, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746-50. (Pubitemid 43985345)
56. • Booty MG, Chae JJ, Masters SL, et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum. 2009, 60:1851-1861. This study described patients with classical features of FMF despite a single MEFV mutation.
57. Ustek D, Ekmekci C, Oku B, et al. MEFV gene 3'-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever. Clin Exp Rheumatol. 2008, 26:S72-6.
58. • Ben-Chetrit E, Peleg H, Aamar S, Heyman SN. The spectrum of MEFV clinical presentations-is it familial Mediterranean fever only? Rheumatology (Oxford). 2009, 48:1455-1459. This study discusses the atypical autoinflammatory clinical features in patients carrying MEFV variations.
59. Kone-Paut I, Hentgen V Guillaume-Czitrom S, et al. The clinical spectrum of 94 patients carrying a single mutated MEFV allele. Rheumatology (Oxford). 2009;48:840-2.
60. Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behcet's disease. Hum Mutat. 2000;16:271-2.